ArticleIrish journal of medical science2022
Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
Article in Irish journal of medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 29 citations in OpenAlex.
- Effect of nursing risk management on treatment compliance and family psychological status in pediatric patients with idiopathic thrombocytopenic purpura.American journal of translational research · 2025Article
- Association Between Influenza Vaccine and Immune Thrombocytopenia: A Systematic Review and Meta-Analysis.Vaccines · 2024Review
- Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients.Antibodies (Basel, Switzerland) · 2024Article
- Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.Infectious diseases and therapy · 2023Article
- Immune thrombocytopaenic purpura following the second dose of Pfizer COVID-19 vaccine.BMJ case reports · 2022Article
- Immune thrombocytopenic purpura induced by the COVID-19 vaccine after the second dose in a 78-year-old patient: A case report.Experimental and therapeutic medicine · 2022Article
- Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports.Clinical and experimental vaccine research · 2022Article
- Article
- Selective COVID-19 Coinfections in Diabetic Patients with Concomitant Cardiovascular Comorbidities Are Associated with Increased Mortality.Pathogens (Basel, Switzerland) · 2022Article
- Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review.BioMed research international · 2022Review
- Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection.Vaccines · 2021Article
- A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.Journal of Korean medical science · 2021Article
- Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis.Medicina (Kaunas, Lithuania) · 2021Review
- Immune thrombocytopenia secondary to COVID-19 infection: Report of two cases.Pediatric blood & cancer · 2021Article
- Possible HSP reactivation post-COVID-19 vaccination and booster.Clinical case reports · 2021Article
- Immune thrombocytopenia in 2 healthy young women after the Pfizer-BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination.Journal of the American College of Emergency Physicians open · 2021Article
- Oxford-AstraZeneca Coronavirus Disease-2019 Vaccine-Induced Immune Thrombocytopenia on Day Two.Case reports in hematology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBased on the severity of thrombocytopenia, patients with immune thrombocytopenic purpura (ITP) are at an increased risk of mucocutaneous or major bleeding. DISCUSSION: There has been an increased risk of ITP after administration of various vaccines like influenza, measles-mumps-rubella, hepatitis B, and diphtheria-tetanus-pertussis. The pathogenesis of vaccine-related thrombocytopenia is not completely clear and is probably caused by molecular mimicry. Till date, there have been few reported cases of thrombocytopenia in the pharmacovigilance databases after patients received the Pfizer and Moderna coronavirus disease-19 (COVID-19) vaccines.
conclusionEmergency physicians should be aware of the occurrence of vaccine-induced ITP in patients who present with bleeding manifestations, especially after the current boost in COVID-19 vaccination drive worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.